cancer molecular diagnostics
Scope
Date
~
-
Bio & Pharma
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Noul, CDC to start Malaria diagnosis project in Kenya
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said o...
Jun 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Korean biotech Bertis to join BIO 2024 for global reach
South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...
May 29, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom launches AI pet diagnostic solution in Australia
South Korea's SK Telecom Co. announced on Wednesday that it launched its AI-based pet diagnostic assistance service X Caliber in Australia and has b...
May 29, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK shieldus, Yokogawa Electric Korea partner on security business
SK shieldus, the unmanned security subsidiary of SK Group, announced on Wednesday it has signed a business agreement with Yokogawa Electric Korea Co...
May 29, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Lunit buys breast cancer detection AI firm Volpara Health
Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI ...
May 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Bio & Pharma
NGeneBio to transfer NGS tech to UAE company
South Korean medical diagnostic company NGeneBio Co. announced on Tuesday that it signed a contract with the United Arab Emirates (UAE)-based medica...
Apr 30, 2024 (Gmt+09:00)
-
Artificial intelligence
Vuno, Canon to target AI diagnostic market in Japan
South Korea's medical device startup Vuno announced on Monday that its Japanese partner M3AI signed a memorandum of understanding (MOU) with Canon M...
Apr 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Genesystem enters Indian tuberculosis treatment market
Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kit...
Mar 27, 2024 (Gmt+09:00)
-
Artificial intelligence
LG, Jackson Lab to jointly develop AI models for Alzheimer’s, cancers
LG AI Research, the artificial intelligence research arm of South Korea’s LG Group, and the Jackson Laboratory (JAX), a US non-profit biomedic...
Mar 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...
Feb 19, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom to enter Australian pet clinics market in H1
South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...
Feb 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Artificial intelligence
SK Telecom to enter AI pet diagnostic market in US
South Korea’s SK Telecom Co. announced on Wednesday that it has signed with the US-based veterinary diagnostic radiology firm Vetology to laun...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Roche to use Biodyne’s tech for cervical cancer diagnostic kits
Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne...
Jan 16, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit acquires NZ-based AI diagnostics firm Volpara
South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Vo...
Dec 14, 2023 (Gmt+09:00)
-
Electronics
LG Elec launches new medical monitor
LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Access Bio opens second plant in New Jersey
The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...
Dec 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Cytogen, Japan NCCH collaborate on cancer research
South Korea's Cytogen, Inc. announced on Monday it will start cancer research using circulating tumor cells (CTC) with the National Cancer Center Ho...
Nov 20, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit gets FDA approval for AI cancer diagnosis solution
South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...
Nov 14, 2023 (Gmt+09:00)